DMRA — Damora Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Damora Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	100	60.2	33.2	14.2	258
Net Total Accounts Receivable
Net Total Receivables	7.85	2.83	2.76	0.881	1.25
Prepaid Expenses
Total Other Current Assets
Total Current Assets	110	63.9	36.8	16.8	260
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.04	1.17	0.325	0.13	0.104
Long Term Investments
Other Long Term Assets
Total Assets	122	73.2	38.2	17.1	261
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.54	11.1	5.83	1.2	20.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.99	11.4	5.9	1.3	20.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	117	61.8	32.3	15.8	240
Total Liabilities & Shareholders' Equity	122	73.2	38.2	17.1	261
Total Common Shares Outstanding